KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Depreciation and Depletion: 2009-2025

Historic Depreciation and Depletion for Acadia Pharmaceuticals (ACAD) over the last 15 years, with Sep 2025 value amounting to $227,000.

  • Acadia Pharmaceuticals' Depreciation and Depletion rose 0.44% to $227,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $895,000, marking a year-over-year decrease of 11.12%. This contributed to the annual value of $920,000 for FY2024, which is 38.67% down from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Depreciation and Depletion stood at $227,000 for Q3 2025, which was up 6.57% from $213,000 recorded in Q2 2025.
  • Acadia Pharmaceuticals' Depreciation and Depletion's 5-year high stood at $616,000 during Q3 2021, with a 5-year trough of $213,000 in Q2 2025.
  • For the 3-year period, Acadia Pharmaceuticals' Depreciation and Depletion averaged around $280,818, with its median value being $229,000 (2025).
  • Per our database at Business Quant, Acadia Pharmaceuticals' Depreciation and Depletion skyrocketed by 82.25% in 2021 and then tumbled by 43.78% in 2024.
  • Over the past 5 years, Acadia Pharmaceuticals' Depreciation and Depletion (Quarterly) stood at $535,000 in 2021, then fell by 8.60% to $489,000 in 2022, then plummeted by 35.99% to $313,000 in 2023, then dropped by 27.80% to $226,000 in 2024, then grew by 0.44% to $227,000 in 2025.
  • Its Depreciation and Depletion stands at $227,000 for Q3 2025, versus $213,000 for Q2 2025 and $229,000 for Q1 2025.